Heparin-induced leukocyte lysis in vitro

Area of Science:

• Biochemistry
• Immunology
• Cell Biology

Background:

• Heparin is widely used as an anticoagulant.
• Its potential effects on leukocytes require further investigation.
• Understanding heparin's cellular interactions is crucial for clinical applications.

Purpose of the Study:

• To investigate the in vitro effects of heparin on leukocytes.
• To elucidate the mechanisms underlying heparin-induced leukocyte damage.
• To identify potential modulators of heparin's cytotoxicity.

Main Methods:

• In vitro assays measuring macromolecule leakage from leukocytes.
• Assessment of heparin's cytotoxic effects.
• Evaluation of the modulatory effects of protamine, ionic conditions, and mepacrine.

Main Results:

• Heparin and other mucopolysaccharides induced significant leukocyte damage, evidenced by macromolecule leakage.
• Heparin's cytotoxicity was attenuated by protamine and a medium mimicking intracellular ionic conditions.
• The phospholipase inhibitor mepacrine suppressed heparin-induced macromolecule leakage, implicating phospholipase activation.

Conclusions:

• Heparin exhibits cytotoxicity towards leukocytes in vitro.
• The mechanism involves heparin-induced phospholipase activation and passive ion flux.
• These findings highlight potential pathways for modulating heparin's effects on leukocytes.